{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T10:10:05Z","timestamp":1755598205250,"version":"3.41.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n          <jats:p>Microsatellitosis is well established as a prognostic factor in malignant melanoma. Its identification leads to subsequent upstaging with implications for further management. We describe 6 cases in which immunohistochemical staining for PReferentially expressed Antigen in MElanoma facilitated detection of small foci of micrometastasis on scanning magnification, which may be potentially missed in routine sections.<\/jats:p>","DOI":"10.1097\/dad.0000000000002817","type":"journal-article","created":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T19:00:31Z","timestamp":1723662031000},"page":"668-671","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Utility of PRAME Immunohistochemistry in the Detection of Subtle Melanoma Microsatellites"],"prefix":"10.1097","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9090-6380","authenticated-orcid":false,"given":"Maged","family":"Daruish","sequence":"first","affiliation":[{"name":"Department of Cellular Pathology, Dorset County Hospital NHS Foundation Trust, Dorchester, United Kingdom; and"},{"name":"Poundbury Cancer Institute, Dorchester, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanwadana","family":"Karunaratne","sequence":"additional","affiliation":[{"name":"Department of Cellular Pathology, Dorset County Hospital NHS Foundation Trust, Dorchester, United Kingdom; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Duffy-Gadd","sequence":"additional","affiliation":[{"name":"Department of Cellular Pathology, Dorset County Hospital NHS Foundation Trust, Dorchester, United Kingdom; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha","family":"Hansford","sequence":"additional","affiliation":[{"name":"Department of Cellular Pathology, Dorset County Hospital NHS Foundation Trust, Dorchester, United Kingdom; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saleem","family":"Taibjee","sequence":"additional","affiliation":[{"name":"Department of Cellular Pathology, Dorset County Hospital NHS Foundation Trust, Dorchester, United Kingdom; and"},{"name":"Poundbury Cancer Institute, Dorchester, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,8,14]]},"reference":[{"key":"R1-20250616","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1074-7613(00)80426-4","article-title":"Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor","volume":"6","author":"Ikeda","year":"1997","journal-title":"Immunity"},{"key":"R2-20250616","doi-asserted-by":"crossref","first-page":"629","DOI":"10.2217\/bmm.12.65","article-title":"The cancer testis antigen PRAME as a biomarker for solid tumor cancer management","volume":"6","author":"Goodison","year":"2012","journal-title":"Biomark Med"},{"key":"R3-20250616","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/DAD.0000000000002440","article-title":"Immunohistochemistry for PRAME in dermatopathology","volume":"45","author":"Lezcano","year":"2023","journal-title":"Am J Dermatopathol"},{"key":"R4-20250616","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/nrc1669","article-title":"Cancer\/testis antigens, gametogenesis and cancer","volume":"5","author":"Simpson","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"R5-20250616","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1097\/PAS.0000000000001134","article-title":"PRAME expression in melanocytic tumors","volume":"42","author":"Lezcano","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R6-20250616","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1097\/PAS.0000000000001492","article-title":"Comparison of immunohistochemistry for PRAME with cytogenetic test results in the evaluation of challenging melanocytic tumors","volume":"44","author":"Lezcano","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"R7-20250616","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/cup.13818","article-title":"PRAME expression in melanocytic proliferations with intermediate histopathologic or spitzoid features","volume":"47","author":"Raghavan","year":"2020","journal-title":"J Cutan Pathol"},{"key":"R8-20250616","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/cup.13876","article-title":"PRAME expression in 155 cases of metastatic melanoma","volume":"48","author":"Gradecki","year":"2021","journal-title":"J Cutan Pathol"},{"key":"R9-20250616","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/cup.14226","article-title":"PRAME expression in melanocytic lesions of the nail","volume":"49","author":"Parra","year":"2022","journal-title":"J Cutan Pathol"},{"key":"R10-20250616","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13000-022-01218-3","article-title":"Cyclin D1 and PRAME expression in distinguishing melanoma in situ from benign melanocytic proliferation of the nail unit","volume":"17","author":"Kim","year":"2022","journal-title":"Diagn Pathol"},{"key":"R11-20250616","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/PAS.0000000000001878","article-title":"Comparative analysis of PRAME expression in 127 acral and nail melanocytic lesions","volume":"46","author":"Santandrea","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"R12-20250616","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/his.14452","article-title":"PRAME expression in melanocytic lesions of the conjunctiva","volume":"79","author":"\u0160ekoranja","year":"2021","journal-title":"Histopathology"},{"key":"R13-20250616","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1111\/cup.14078","article-title":"PRAME immunohistochemistry is useful in the evaluation of conjunctival melanomas, nevi, and primary acquired melanosis","volume":"48","author":"LeBlanc","year":"2021","journal-title":"J Cutan Pathol"},{"key":"R14-20250616","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1097\/DAD.0000000000002201","article-title":"PRAME expression in junctional melanocytic proliferations of the conjunctiva: a potential biomarker for primary acquired melanosis\/conjunctival melanocytic intraepithelial lesions","volume":"44","author":"Huang","year":"2022","journal-title":"Am J Dermatopathol"},{"key":"R15-20250616","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s12105-022-01515-9","article-title":"PRAME staining in sinonasal mucosal melanoma: a single-center experience","volume":"17","author":"Scheurleer","year":"2023","journal-title":"Head Neck Pathol"},{"key":"R16-20250616","doi-asserted-by":"crossref","first-page":"105500","DOI":"10.1016\/j.oraloncology.2021.105500","article-title":"PRAME immunohistochemistry is useful in the diagnosis of oral malignant melanoma","volume":"124","author":"Hovander","year":"2022","journal-title":"Oral Oncol"},{"key":"R17-20250616","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1038\/s41379-019-0335-4","article-title":"Analyses of molecular and histopathologic features and expression of PRAME by immunohistochemistry in mucosal melanomas","volume":"32","author":"Toyama","year":"2019","journal-title":"Mod Pathol"},{"key":"R18-20250616","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000524051","article-title":"Preferentially expressed antigen in melanoma immunohistochemistry labeling in uveal melanomas","volume":"8","author":"Ahmadian","year":"2022","journal-title":"Ocul Oncol Pathol"},{"key":"R19-20250616","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/his.14904","article-title":"Diagnostic test accuracy meta-analysis of PRAME in distinguishing primary cutaneous melanomas from benign melanocytic lesions","volume":"83","author":"Kunc","year":"2023","journal-title":"Histopathology"},{"key":"R20-20250616","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/labinvest.2016.131","article-title":"Lymphatic invasion and angiotropism in primary cutaneous melanoma","volume":"97","author":"Moy","year":"2017","journal-title":"Lab Invest"},{"key":"R21-20250616","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1080\/14737140.2018.1489246","article-title":"The eighth edition American Joint Committee on Cancer (AJCC) melanoma staging system: implications for melanoma treatment and care","volume":"18","author":"Keung","year":"2018","journal-title":"Expert Rev Anticancer Ther"},{"key":"R22-20250616","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3322\/caac.21409","article-title":"Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual","volume":"67","author":"Gershenwald","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"R24-20250616","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1001\/archderm.134.8.983","article-title":"Prediction of sentinel lymph node micrometastasis by histological features in primary cutaneous malignant melanoma","volume":"134","author":"Mraz-Gernhard","year":"1998","journal-title":"Arch Dermatol"},{"key":"R25-20250616","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00008390-200506000-00005","article-title":"Prognostic factors in localized invasive cutaneous melanoma: high value of mitotic rate, vascular invasion and microscopic satellitosis","volume":"15","author":"Nagore","year":"2005","journal-title":"Melanoma Res"},{"key":"R26-20250616","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1200\/JCO.2002.08.024","article-title":"Implications of microscopic satellites of the primary and extracapsular lymph node spread in patients with high-risk melanoma: pathologic corollary of Eastern Cooperative Oncology Group Trial E1690","volume":"20","author":"Rao","year":"2002","journal-title":"J Clin Oncol"},{"key":"R27-20250616","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/archderm.141.6.739","article-title":"The role of microsatellites as a prognostic factor in primary malignant melanoma","volume":"141","author":"Shaikh","year":"2005","journal-title":"Arch Dermatol"},{"key":"R28-20250616","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/s41379-020-0500-9","article-title":"The prognostic significance of microsatellites in cutaneous melanoma","volume":"33","author":"Niebling","year":"2020","journal-title":"Mod Pathol"},{"key":"R30-20250616","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/cup.13874","article-title":"Multiple combinations of melanocytic and vascular endothelial markers enhance the detection rate of lymphovascular invasion in cutaneous melanoma","volume":"48","author":"Bayram","year":"2021","journal-title":"J Cutan Pathol"},{"key":"R31-20250616","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/DAD.0000000000000453","article-title":"Prognostic implication of lymphovascular invasion detected by double immunostaining for D2-40 and MITF1 in primary cutaneous melanoma","volume":"38","author":"Feldmeyer","year":"2016","journal-title":"Am J Dermatopathol"}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000002817","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T18:01:39Z","timestamp":1750096899000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000002817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,14]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0000000000002817","relation":{},"ISSN":["0193-1091"],"issn-type":[{"type":"print","value":"0193-1091"}],"subject":[],"published":{"date-parts":[[2024,8,14]]}}}